Tania Palanché

TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial

Élisabeth Quoix, H. Léna, György Losonczy et al. · The Lancet Oncology · 2015 · 199 citations

First-line Chemotherapy, Phase 2B, Medicine +8

The Neurokinin A Receptor Activates Calcium and cAMP Responses through Distinct Conformational States

Tania Palanché, Brigitte Ilien, Sannah Zoffmann et al. · Journal of Biological Chemistry · 2001 · 128 citations · Full text

Fluorescent siderophore-based chemosensors: iron(III) quantitative determinations

Tania Palanché, Frank Marmolle, Mohamed A. Abdallah et al. · JBIC Journal of Biological Inorganic Chemistry · 1999 · 71 citations

Chemical Measurement, Biochemistry, Fluorescent Siderophore-based Chemosensors +7

Optimal Inhibition of X4 HIV Isolates by the CXC Chemokine Stromal Cell-derived Factor 1α Requires Interaction with Cell Surface Heparan Sulfate Proteoglycans

Agustı́n Valenzuela-Fernández, Tania Palanché, Ali Amara et al. · Journal of Biological Chemistry · 2001 · 68 citations · Full text

Bacterial Iron Transport:  Coordination Properties of Azotobactin, the Highly Fluorescent Siderophore of<i>Azotobacter v</i><i>inelandii</i>

Tania Palanché, Sylvie Blanc, Christophe Hennard et al. · Inorganic Chemistry · 2003 · 45 citations